You're not imagining it, and it's increasingly well-documented.
Several studies and clinical trials have shown that GLP-1 receptor agonists significantly reduce alcohol intake in both animal models and humans:1,2
The mechanism is believed to work through the same reward pathway modulation that reduces food noise:
- GLP-1 receptors in the nucleus accumbens and ventral tegmental area modulate dopamine release in response to rewarding stimuli
- Alcohol triggers dopamine release in these same circuits
- GLP-1 RAs appear to reduce the "wanting" (incentive salience) for alcohol just as they do for food
- Preclinical studies show semaglutide reduces alcohol intake by 40-60% in alcohol-preferring rodent models3
There are currently clinical trials underway specifically investigating semaglutide as a treatment for alcohol use disorder. Early results are very promising.
This is NOT your imagination. Your reward circuitry is being recalibrated.
1 Klausen et al., "GLP-1 receptor agonists reduce alcohol intake," JCI Insight, 2022.
2 Probst et al., "GLP-1 RA and alcohol consumption: a systematic review," Addiction Biology, 2023.
3 Sirohi et al., "Central and peripheral GLP-1 receptor signaling differentially regulate addictive behaviors," Pharmacology Biochemistry and Behavior, 2016.